SoFi Technologies (NASDAQ:SOFI) and Affirm Holdings (NASDAQ:AFRM) were rising after William Blair initiated coverage of the ...

William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...

Investment analysts at William Blair boosted their FY2024 earnings per share (EPS) estimates for shares of Watsco in a ...

Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...

William Blair analyst Margaret Kaczor upgraded CVRx (CVRX) to Outperform from Market Perform without a price target With now several solid quarters behind it following ithe Q1 of 2024 miss and ...

"It is my pleasure to welcome Terence to William Blair's Healthcare investment banking practice and its biopharma group," said Steve Tole, head of Healthcare investment bankin at William Blair. "Our ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

Portillo’s has never been one to follow the worn path in quick service. It hasn’t engaged in the “value wars” or materially ...

William Blair Small-Mid Cap Core Fund earns an Average Process Pillar rating. The predominant contributor to the rating is the fund's strong long-term risk-adjusted performance. This can be seen ...

William Blair International Growth Fund earns an Average Process Pillar rating. The most important driver of the rating is the stability of the management team. Specifically, the fund has not seen ...

The Fund seeks long-term capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of equity securities, including common ...

Biogen’s proposed acquisition comes after two difficult years of regulatory and clinical challenges, during which shares of ...